Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ANZUW NASDAQ:CNXU NASDAQ:DRTSW NASDAQ:QTEX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANZUWAnzu Special Acquisition Corp I$0.05$0.06$0.00▼$0.15N/AN/A32,101 shs34 shsCNXUConexeu Sciences$17.24+2.4%$0.00$10.87▼$18.79$435.66MN/A109,083 shs105,810 shsDRTSWAlpha Tau Medical$2.33+21.4%$1.41$0.20▼$2.99N/AN/A56,269 shs50,631 shsQTEXInspira Technologies OXY B.H.N.$2.36+1.7%$0.00$0.28▼$3.85$84.84M4.1113.88 million shs15.58 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANZUWAnzu Special Acquisition Corp I0.00%-27.69%-33.76%+15.25%-28.97%CNXUConexeu Sciences+19.26%+22.29%+1,683,999,900.00%+1,683,999,900.00%+1,683,999,900.00%DRTSWAlpha Tau Medical-18.30%-25.00%+43.71%+95.92%+814.29%QTEXInspira Technologies OXY B.H.N.-24.68%+231,999,900.00%+231,999,900.00%+231,999,900.00%+231,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANZUWAnzu Special Acquisition Corp I$0.05$0.06$0.00▼$0.15N/AN/A32,101 shs34 shsCNXUConexeu Sciences$17.24+2.4%$0.00$10.87▼$18.79$435.66MN/A109,083 shs105,810 shsDRTSWAlpha Tau Medical$2.33+21.4%$1.41$0.20▼$2.99N/AN/A56,269 shs50,631 shsQTEXInspira Technologies OXY B.H.N.$2.36+1.7%$0.00$0.28▼$3.85$84.84M4.1113.88 million shs15.58 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANZUWAnzu Special Acquisition Corp I0.00%-27.69%-33.76%+15.25%-28.97%CNXUConexeu Sciences+19.26%+22.29%+1,683,999,900.00%+1,683,999,900.00%+1,683,999,900.00%DRTSWAlpha Tau Medical-18.30%-25.00%+43.71%+95.92%+814.29%QTEXInspira Technologies OXY B.H.N.-24.68%+231,999,900.00%+231,999,900.00%+231,999,900.00%+231,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANZUWAnzu Special Acquisition Corp I 0.00N/AN/AN/ACNXUConexeu Sciences 0.00N/AN/AN/ADRTSWAlpha Tau Medical 0.00N/AN/AN/AQTEXInspira Technologies OXY B.H.N. 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest QTEX, DRTSW, ANZUW, and CNXU Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/27/2026QTEXInspira Technologies OXY B.H.N. Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageSell (E+)(Data available from 6/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AN/ACNXUConexeu SciencesN/AN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AN/AQTEXInspira Technologies OXY B.H.N.$289K261.22N/AN/A$0.06 per share35.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AN/AN/AN/AN/ACNXUConexeu SciencesN/AN/AN/AN/AN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AN/AN/AN/A8/18/2026 (Estimated)QTEXInspira Technologies OXY B.H.N.-$13.22MN/AN/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/ACNXUConexeu SciencesN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AQTEXInspira Technologies OXY B.H.N.N/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioANZUWAnzu Special Acquisition Corp IN/AN/AN/ACNXUConexeu SciencesN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AQTEXInspira Technologies OXY B.H.N.0.081.561.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANZUWAnzu Special Acquisition Corp IN/ACNXUConexeu SciencesN/ADRTSWAlpha Tau MedicalN/AQTEXInspira Technologies OXY B.H.N.12.72%Insider OwnershipCompanyInsider OwnershipANZUWAnzu Special Acquisition Corp IN/ACNXUConexeu SciencesN/ADRTSWAlpha Tau MedicalN/AQTEXInspira Technologies OXY B.H.N.29.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANZUWAnzu Special Acquisition Corp I2N/AN/ANot OptionableCNXUConexeu Sciences425.27 millionN/AN/ADRTSWAlpha Tau Medical80N/AN/ANot OptionableQTEXInspira Technologies OXY B.H.N.2035.95 million25.38 millionN/AQTEX, DRTSW, ANZUW, and CNXU HeadlinesRecent News About These CompaniesQTREX to Showcase Functional AME-Based Monolithic Connectivity Components for Quantum Computing Systems at Quantum.Tech World 2026 in BostonJune 2 at 7:30 AM | globenewswire.comQTREX Quantum (QTEX) Is Up 322.3% After $10M Private Placement And Nasdaq Rebrand – What's ChangedJune 2 at 5:09 AM | finance.yahoo.comQTREX Secures Purchase Order from a U.S.-based Fortune 500 company for an AME System and Related MaterialsJune 1 at 9:20 AM | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeQTEX, DRTSW, ANZUW, and CNXU Company DescriptionsAnzu Special Acquisition Corp I NASDAQ:ANZUW$0.05 0.00 (0.00%) As of 06/1/2026Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Conexeu Sciences NASDAQ:CNXU$17.24 +0.40 (+2.38%) As of 12:39 PM EasternConexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. --- Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property ("IP") developed over more than a decade at the University of British Columbia (the "University") and the BC Professional Firefighters Burn and Wound Healing Laboratory. In November 2023, the Company entered into a patent assignment agreement with the University pursuant to which the Company acquired an assignment of the University's right, title, and interest in the applicable patents and patent applications related to the underlying technology. The Company's only device candidate is the CXU™ scaffold device candidate, which is in preclinical development and has not been approved or cleared for marketing in any jurisdiction. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications. Any potential benefits to patients, providers, or healthcare systems have not been established and will require further study and regulatory review. CXU™ is a temperature-responsive, collagen-based extracellular matrix ("ECM") formulation designed to transition from a liquid to a gel-like scaffold following topical application or injection, typically within approximately ten minutes (the "10 Minute Tissue™" concept). The device IP is protected by issued and pending patents and is being evaluated in preclinical studies for its ability to provide an ECM-like environment associated with cellular infiltration, vascularization, and organized tissue remodeling in non-clinical models. We intend to seek U.S. Food and Drug Administration ("FDA") clearance in the United States for the CXU™ scaffold device candidate through the 510(k) premarket notification process as a Class II medical device; however, the FDA has not yet determined the appropriate classification or regulatory pathway for our device candidate, may require additional data or a different pathway, and there can be no assurance that we will obtain clearance or that the device candidate will become commercially available. Our principal executive offices are located in Reno, Nevada.Alpha Tau Medical NASDAQ:DRTSW$2.33 +0.41 (+21.35%) As of 12:39 PM EasternAlpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.Inspira Technologies OXY B.H.N. NASDAQ:QTEX$2.36 +0.04 (+1.72%) As of 12:40 PM EasternInspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Build 2026 Is Really Just One Big AI Stress Test Slice of the Pie: Why Yum’s Deal Lifts QSR Urban Outfitters Stock Stalls Despite Another Strong Quarter Marvell Stock Soars on NVIDIA's Trillion-Dollar Nod MongoDB Is the Latest SaaS Apocalypse Victim to Say "Not Today" Dollar General Signals Reversal With 60% Rebound Potential Kohl's Stock Soars After Better-Than-Feared Quarter Credo Technologies Paved a Path to a $300 Price Point Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
